Related Experiment Video

Updated: Jun 25, 2026

Adenovirus-mediated Genetic Removal of Signaling Molecules in Cultured Primary Mouse Embryonic Fibroblasts
11:00

Adenovirus-mediated Genetic Removal of Signaling Molecules in Cultured Primary Mouse Embryonic Fibroblasts

Published on: September 10, 2010

Mumps and rubella eliminated from Finland

H Peltola1, I Davidkin, M Paunio

  • 1Hospital for Children and Adolescents, PO Box 281, FIN-00029 HUS, Helsinki, Finland. heikki.peltola@hus.fi

JAMA
|November 22, 2000
PubMed

Insights

Finland

Area of Science:

  • Immunology
  • Vaccinology
  • Public Health

Background:

  • Finland implemented a national 2-dose measles-mumps-rubella (MMR) vaccination program in 1982.
  • Mandatory serological confirmation of suspected mumps and rubella cases was established in 1987.
  • No vaccine-related deaths or sequelae have been reported.

Purpose of the Study:

  • To evaluate the impact of a 2-dose MMR vaccination program on mumps and rubella elimination in Finland.
  • To assess the long-term effectiveness of the vaccination strategy in preventing indigenous disease and outbreaks.

Main Methods:

  • Analysis of national vaccination coverage data from 1982 to 1999.
  • Surveillance of mumps and rubella cases, including imported and indigenous infections.
  • Monitoring for vaccine-related adverse events.

Main Results:

  • Indigenous mumps and rubella were eliminated by 1996.
  • High community immunity prevented secondary spread from imported cases (1997-1999).
  • Annual prevention of thousands of mumps complications and congenital rubella syndrome cases.

Conclusions:

  • A 2-dose MMR vaccination policy effectively eliminated indigenous mumps and rubella in Finland.
  • Sustained high vaccination coverage is crucial for preventing future outbreaks.
  • Finland serves as a model for successful vaccine-preventable disease eradication.

More Related Videos

Immunization of Adult Zebrafish for the Preclinical Screening of DNA-based Vaccines05:39

Immunization of Adult Zebrafish for the Preclinical Screening of DNA-based Vaccines

Published on: October 30, 2018

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay09:14

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay

Published on: January 26, 2019

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Investigation of Disease Outbreaks01:23

Investigation of Disease Outbreaks

Multistate foodborne outbreaks pose significant public health risks and require meticulous investigation to identify sources and implement control measures. The Centers for Disease Control and Prevention (CDC) utilizes a dynamic seven-step process for these investigations, integrating data from laboratories, interviews, and environmental assessments to protect public health.Outbreak Detection: The detection of multistate outbreaks typically begins with PulseNet, the CDC's national laboratory...
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...